Adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic ovarian cancer: A pilot study

被引：0
|
作者：
Pedersen, M. [1 ,2 ]
Westergaard, M. [1 ,2 ]
Nielsen, M. [1 ,2 ]
Borch, T. H. [1 ,2 ]
Poulsen, L. G. [3 ]
Hendel, H. [4 ]
Juhler-Nottrup, T. [5 ]
Met, O. [1 ,2 ]
Donia, M. [1 ,2 ]
Svane, I-M. [1 ,2 ]
机构：
[1] Herlev & Gentofte Hosp, Ctr Canc Immune Therapy, Dept Haematol, Herlev, Denmark
[2] Herlev & Gentofte Hosp, Dept Oncol, Herlev, Denmark
[3] Herlev & Gentofte Hosp, Dept Gynecol & Obstet, Herlev, Denmark
[4] Herlev & Gentofte Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark
[5] Rigshosp, Dept Oncol, Copenhagen, Denmark
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1145PD
引用
收藏
页数：1
相关论文
共 50 条
  • [21] LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes in patients with metastatic soft tissue sarcoma.
    Nielsen, Morten
    Monberg, Tine
    Albieri, Benedetta
    Sundvold, Vibeke
    Rekdal, Oystein
    Junker, Niels
    Svane, Inge Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Adoptive Cell Therapy Using Expanded Autologous Tumor-infiltrating Lymphocytes in Metastatic Melanoma Patients: Role of Specific Lymphocyte Subsets
    Bernatchez, Chantale
    Zhang, Minying
    Fox, Patricia S.
    Chacon, Jessica Ann
    Wu, Cheng-Han
    Lizee, Gregory
    Mahoney, Sandy L.
    Alvarado, Gladys
    Mansaray, Rahmatu
    Fulbright, Orenthial J.
    Toth, Christopher L.
    Ramachandran, Renjith
    Wardell, Seth
    Gonzalez, Audrey M.
    Hwu, Patrick
    Radvanyi, Laszlo
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 721 - 721
  • [23] Pilot Trial of Ipilimumab and Adoptive Tumor-infiltrating Lymphocyte (TIL) Cell Therapy
    Prabhakaran, S.
    Woods, D. M.
    Royster, E. B.
    Zager, J. S.
    Sondak, V. K.
    Pilon-Thomas, S.
    Sarnaik, A. A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S23 - S23
  • [24] Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for the treatment of bladder cancer.
    Bunch, Brittany L.
    Morse, Jennifer
    Asby, Sarah
    Poch, Michael
    Pilon-Thomas, Shari
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 31 - 31
  • [25] A NEW APPROACH TO THE ADOPTIVE IMMUNOTHERAPY OF CANCER WITH TUMOR-INFILTRATING LYMPHOCYTES
    ROSENBERG, SA
    SPIESS, P
    LAFRENIERE, R
    SCIENCE, 1986, 233 (4770) : 1318 - 1321
  • [26] Preclinical development of tumor-infiltrating lymphocytes (TILs) based adoptive cell transfer immunotherapy (ACT) for patients with advanced ovarian cancer
    Westergaard, M. C. W.
    Andersen, R.
    Kjeldsen, J. W.
    Hasselager, T.
    Lajer, H.
    Donia, M.
    Svane, I. -M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer
    Lee, Hee Jin
    Kim, Young-Ae
    Sim, Chan Kyu
    Heo, Sun-Hee
    Song, In Hye
    Park, Hye Seon
    Park, Suk Young
    Bang, Won Seon
    Park, In Ah
    Lee, Miseon
    Lee, Jung Hoon
    Cho, Yeon Sook
    Chang, Suhwan
    Jung, Jaeyun
    Kim, Jisun
    Lee, Sae Byul
    Kim, Sung Youl
    Lee, Myeong Sup
    Gong, Gyungyub
    ONCOTARGET, 2017, 8 (69) : 113345 - 113359
  • [28] Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
    Mullinax, John E.
    Egger, Michael E.
    McCarter, Martin
    Monk, Bradley J.
    Toloza, Eric M.
    Brousseau, Susan
    Jagasia, Madan
    Sarnaik, Amod
    CANCER JOURNAL, 2022, 28 (04): : 285 - 293
  • [29] Successful Generation of Tumor-Infiltrating Lymphocytes (TIL) for Adoptive Cell Therapy from Mesothelioma
    Fennell, D. A.
    Poile, C.
    Bzura, A.
    Dzialo, J.
    Nakas, A.
    Kutywayo, K.
    Natarajan, A.
    Herman, C.
    Kovatch, R.
    Bunch, B.
    Veerapathran, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S381 - S382
  • [30] Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions
    Granhoj, Joachim Stoltenborg
    Jensen, Agnete Witness Praest
    Presti, Mario
    Met, Ozcan
    Svane, Inge Marie
    Donia, Marco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 627 - 641
12345